Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Bhuller · SciRah

Researcher profile · Semantic Scholar

K. Bhuller

Share profile

K. Bhuller — researcher profile on SciRah

h-index: 9
Works: 24
Citations: 328

Most-cited papers

Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia
N. Cross, Yvette Hoade, W. Tapper, Gonzalo Carreño-Tarragona +32 more
2018Leukemia74 citations Open access
Semantic Scholar
Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphoma
M. Ahearne, K. Bhuller, Roger Hew, Hazem A. H. Ibrahim +2 more
2014Virchows Archiv69 citations
Semantic Scholar
Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer
K. Bhuller, Yang Zhang, Dongdong Li, L. Sehn +3 more
2016British Journal of Haematology51 citations Open access
Semantic Scholar
Guideline for the first‐line management of Classical Hodgkin Lymphoma — A British Society for Haematology guideline
G. Follows, S. Barrington, K. Bhuller, D. Culligan +8 more
2022British Journal of Haematology33 citations Open access
Semantic Scholar
Diagnostic dilemma of Hodgkin’s lymphoma versus tuberculosis: a case report and review of the literature
A. Banerjee, K. Bhuller, R. Sudhir, A. Bajaj
2021Journal of Medical Case Reports25 citations Open access
Semantic Scholar
Risk stratification in febrile neutropenic episodes in adolescent/young adult patients with cancer.
R. Phillips, K. Bhuller, L. Sung, R. Ammann +3 more
2016European Journal of Cancer19 citations Open access
Semantic Scholar
Recurrent activating STAT 5 B N 642 H mutation in myeloid neoplasms 1 with eosinophilia
N. Cross, Yvette Hoade, William Tapper, Gonzalo Carreño-Tarragona +34 more
201816 citations
Semantic Scholar
The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study.
A. Santarsieri, E. Mitchell, M. H. Pham, R. Sanghvi +52 more
2024The Lancet Oncology10 citations Open access
Semantic Scholar
Replacing Procarbazine with Dacarbazine in Escalated Beacopp Dramatically Reduces the Post Treatment Haematopoietic Stem and Progenitor Cell Mutational Burden in Hodgkin Lymphoma Patients with No Apparent Loss of Clinical Efficacy
A. Santarsieri, E. Mitchell, K. Sturgess, P. Brice +42 more
2022Blood9 citations Open access
Semantic Scholar
Real World Escalated Beacopdac Delivers Similar Outcomes to Escalated Beacopp and Superior Outcomes to Response-Adapted (RATHL) ABVD, While Potentially Reducing Toxicity Compared with Escalated Beacopp
A. Santarsieri, K. Sturgess, P. Brice, T. Menne +30 more
2021Blood8 citations
Semantic Scholar
Managing pain and anxiety in adult bone marrow examinations: combining pharmacological and psychological approaches.
S. Lord, K. Bhuller
2012Journal of Pain and Symptom Management7 citations Open access
Semantic Scholar
Acute promyelocytic leukaemia presenting with subarachnoid haemorrhage and complicated by central nervous system involvement
K. Bhuller, M. Kwan
2011Blood Cancer Journal2 citations Open access
Semantic Scholar
Relapsed/Refractory Hodgkin lymphoma after first-line escalated beacopdac: Adverse outcomes are overcome by use of second-line targeted therapy - an international real-world analysis
Lisa Jeffers, A. Santarsieri, Wendy Osborne, F. Chevillon +20 more
2025Blood1 citations
Semantic Scholar
Clinical impact of recent surge in acute parvovirus B19 infections in Leicester UK, March–July 2024
Nabila Tabassum, K. Bhuller, Amy Webster, F. Siddiqui +16 more
2024Journal of Medical Virology1 citations
Semantic Scholar
Replacing procarbazine with dacarbazine in escalated BEACOPP reduces clinical toxicity with no loss of efficacy yet protects stem cells from excess somatic mutational damage
A. Santarsieri, E. Mitchell, R. Sanghvi, H. Lee-Six +47 more
2023Hematological Oncology1 citations Open access
Semantic Scholar
Reduced Intensity Reinduction Followed By Blinatumomab Achieves Excellent MRD Clearance with Reduced Toxicity and Facilitates Timely Transplant in Children and Young People with Relapsed B-Precursor Acute Lymphoblastic Leukemia
A. Hodder, A. Mishra, Katherine Clesham, S. Baird +32 more
2022Blood1 citations Open access
Semantic Scholar
P015: Real World Escalated BEACOPDac Delivers Similar Outcomes to Escalated BEACOPP While Potentially Reducing Haematopoietic and Reproductive Toxicity
A. Santarsieri, K. Sturgess, P. Brice, T. Menne +37 more
2022HemaSphere1 citations Open access
Semantic Scholar
EARLY RESPONSE AND GENETICS DEFINE RELAPSE RISK AFTER FRONTLINE BLINATUMOMAB IN CHILDHOOD B-ALL: A COHORT STUDY.
Miguel Vieira Martins, A. Enshaei, Yang-Yang Wang, J. Gibson +35 more
2026Blood Advances0 citations Open access
Semantic Scholar
Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia
A. Hodder, Avijeet Mishra, A. Enshaei, S. Baird +42 more
2026Leukemia0 citations Open access
Semantic Scholar
Flowrna in the Diagnosis of EBV-Related Lymphoproliferative Disease
Alexander Glover, M. Bishton, M. Ahearne, K. Bhuller +9 more
2023Blood0 citations Open access
Semantic Scholar
MODIFICATION OF ESCALATED BEACOPP WITH DACARBAZINE SUBSTITUTION REDUCES TOXICITY WHILE MAINTAINING EFFICACY FOR THE TREATMENT OF ADVANCED STAGE HODGKIN LYMPHOMA
A. Santarsieri, K. Sturgess, P. Brice, T. Menne +22 more
2021Hematological Oncology0 citations Open access
Semantic Scholar
198 | MATURE RESULTS FROM A PHASE II TRIAL OF BRENTUXIMAB VEDOTIN PLUS ADRIAMYCIN AND DACARBAZINE WITHOUT RADIATION IN NON ‐ BULKY LIMITED STAGE CLASSICAL HODGKIN LYMPHOMA
A. Santarsieri, K. Sturgess, P. Brice, T. Menne +27 more
20210 citations
Semantic Scholar
A Variety of T-Cell Subsets Contribute to CD4+ T-Cell Infiltration in Diffuse Large B-Cell Lymphoma and Both Total CD4+ and CD4+FoxP3+ T-Cell Numbers Predict Clinical Outcome,
M. Ahearne, K. Bhuller, Roger Hew, G. Roncador +4 more
20110 citations
Semantic Scholar
Epidemiology of Pneumocystis Jirovecii Pneumonia in Non HIV Infected Patients in a Tertiary Care Hospital in the UK
S. Alleyne, Sarah Wharin, N. Perera, K. Bhuller +1 more
20090 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Uttenthal×8
Invite
B. Uttenthal — researcher profile on SciRah
A. Santarsieri×8
Invite
A. Santarsieri — researcher profile on SciRah
G. Follows×7
Invite
G. Follows — researcher profile on SciRah
T. Menne×7
Invite
T. Menne — researcher profile on SciRah

×7

Invite

S. Behan — researcher profile on SciRah

K. Cwynarski×7

Invite

K. Cwynarski — researcher profile on SciRah

S. Nagumantry×7

Invite

S. Nagumantry — researcher profile on SciRah

Invite

G. Stafford — researcher profile on SciRah

E. Gallop‐Evans×6

Invite

E. Gallop‐Evans — researcher profile on SciRah

Invite

W. Osborne — researcher profile on SciRah

Invite

T. Creasey — researcher profile on SciRah

Invite

K. Ardeshna — researcher profile on SciRah